Comparing the current results to its competitors, Science 37 Holdings Inc reported Revenue decrease in the 3 quarter 2023 year on year by -8.38 %, slower than the combined decrease of the SNCE's competitors by -31.2 %, recorded in the same quarter.
Science 37 Holdings Inc , slower than the average decrease reported by the company's competitors of -27.18 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -27.18 %
despite revenue deterioration, Science 37 Holdings Inc increased its market share in this segment. company increased its market share in this segment to approximately 0.41 %.
May 2, 2024
Clinical trials are crucial for evaluating the safety and efficacy of new treatments, including those for asthma. Patient enrollment in trials is often a lengthy and costly process, impacting the timely development and availability of novel therapies. However, Science 37 s innovative Metasite and Patient Recruitment Solutions have emerged as game-changers, demonstrating a remarkable 22x faster enrollment in a Phase 3 asthma clinical trial.Background:Traditionally, patient enrollment in clinical trials has been impeded by various challenges, such as geographical limitations, limited access to trial sites, low patient awareness, and high dropout rates. These obstacles contribute to prolonged trial durations a...
Clarus Corporation operates as a technology company that provides software solutions for the financial and legal sectors. Their business model revolves around developing and offering proprietary software products and services to help organizations streamline operations, improve efficiency, and enhance decision-making processes. With a focus on innovation and customer satisfaction, Clarus Corporation aims to deliver cutting-edge solutions that drive growth and success for their clients.
Icon Plc is a leading provider of clinical research services, specializing in the design and management of clinical trials for pharmaceutical and biotechnology companies. Their business model focuses on offering a comprehensive range of services, including study design, data management, regulatory support, and statistical analysis, to support the development of new drugs and medical devices. Icon Plc's success lies in its ability to provide customized solutions to its clients, efficiently navigate the regulatory landscape, and consistently deliver high-quality and timely results.
Labcorp Holdings Inc operates as a major healthcare diagnostics company, providing clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model emphasizes delivering accurate and timely test results to aid in patient diagnosis, treatment, and monitoring.
Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.
Syneos Health Inc's business model revolves around offering end-to-end solutions in the pharmaceutical and biotechnology industry. They provide a comprehensive range of services, including clinical research, commercialization, consulting, and technology solutions to help clients accelerate the development and delivery of innovative therapies. By integrating various aspects of the industry, Syneos Health aims to improve efficiency, drive productivity, and ultimately support the success of their clients' healthcare products.
Sources:
Science 37 Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Science 37 Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
